A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...
Yet another study is supporting the notion that the blockbuster GLP-1 drug Ozempic can help problems drinkers curb their ...
A medical director of liver transplants in Colorado says he has noticed a worrying rise in the number of young people in ...
Health risks caused by alcohol have received new scrutiny recently, and federal data show the annual number of drug-related ...
Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...
The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...
Loneliness and social isolation have been linked to an elevated risk of non-alcoholic fatty liver disease (NAFLD), according ...
The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol intake, according to new USC research.
The research found that heavy drinkers with either diabetes, high blood pressure or a high waist circumference are as much as 2.4 times more likely to develop advanced liver disease.
The risk of serious liver damage from alcohol is more than twice as high for people with belly fat and diabetes, a new study found.
The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut ...
A growing number of young Americans are drinking their way onto the organ transplant list — particularly women.